Premature Ejaculation Treatment: Virtual Care for Canadian Men
TelePlus Care provides discreet, evidence-based premature ejaculation (PE) treatment through virtual consultations with Alberta-licensed physicians. PE is the most common male sexual dysfunction, affecting roughly 1 in 3 men at some point in their lives, and it is highly treatable with a combination of behavioral techniques, topical anesthetic agents, and certain prescription medications. We evaluate the type of PE (lifelong vs acquired), screen for contributing factors such as anxiety or erectile dysfunction, and design a personalized treatment plan. The consultation is completed by video, and any prescriptions are issued for you to fill at any Canadian pharmacy.
Book Your Appointment Now
Premature ejaculation (PE) is defined as ejaculation occurring within approximately one minute of vaginal penetration with associated distress, affecting 20-30% of men globally. Treatment options include behavioral techniques (start-stop, squeeze method), topical anesthetic creams or sprays (lidocaine-prilocaine), and off-label SSRIs (paroxetine, sertraline) or on-demand dapoxetine where available. TelePlus Care prescribes virtually after physician evaluation.
- Premature ejaculation affects approximately 20-30% of men worldwide, making it the most common male sexual dysfunction (International Society for Sexual Medicine)
- Diagnostic criteria: ejaculation within approximately 1 minute of penetration (lifelong PE) or a clinically significant reduction in latency (acquired PE), with distress
- Topical lidocaine-prilocaine 5% cream applied 20-30 minutes before sex can increase intravaginal ejaculation latency time by 6-8 fold
- Off-label SSRIs (paroxetine 20 mg, sertraline 50-100 mg) are the most-studied oral treatments; dapoxetine is approved in many countries but not currently marketed in Canada
What Is Premature Ejaculation?
Premature ejaculation (PE) is defined by the International Society for Sexual Medicine as ejaculation that occurs within approximately one minute of vaginal penetration (lifelong PE) or a bothersome reduction in ejaculation latency to about three minutes or less (acquired PE), accompanied by an inability to delay ejaculation and personal distress.
PE is the most common male sexual dysfunction, affecting roughly 20-30% of men at some point. It is distinct from erectile dysfunction, although the two often coexist; treating ED first is often necessary because anxiety about losing an erection can drive premature ejaculation. PE is highly treatable, and most men respond to a combination of behavioral, topical, and pharmacological strategies.
Causes and Contributing Factors
PE has biological, psychological, and relational contributing factors. A proper consultation explores all of them to build an effective treatment plan.
- Neurobiological factors -- Differences in serotonin neurotransmission are implicated in lifelong PE; this is why SSRIs are effective.
- Erectile dysfunction -- Anxiety about losing an erection often drives faster ejaculation; treating ED frequently improves PE.
- Anxiety and stress -- Performance anxiety, relationship stress, and depression are common contributors.
- Hormonal factors -- Hyperthyroidism and other hormonal conditions can shorten latency; addressed with bloodwork if indicated.
- Prostatitis or chronic pelvic pain -- These conditions are associated with acquired PE.
- Habit and conditioning -- Earlier patterns (e.g. rushed masturbation) can shape ejaculation reflexes that benefit from behavioral retraining.
Who Is a Candidate for PE Treatment?
Most adult men with PE are candidates for evaluation and treatment. Treatment is selected based on whether PE is lifelong or acquired and based on co-occurring conditions.
- Adult men aged 18+ -- Treatment is appropriate for men whose PE causes personal or relational distress.
- Lifelong PE (since first sexual experiences) -- Often responsive to SSRIs and topical anesthetics.
- Acquired PE (recent onset) -- Requires evaluation for ED, anxiety, prostatitis, or thyroid dysfunction.
- Co-occurring ED -- Often treated first; PDE5 inhibitor therapy alone resolves PE in many men with both conditions.
- Medication review -- Current medications, especially SSRIs, MAOIs, and tramadol, are reviewed for interactions before any new prescription.
- Medical history -- Cardiovascular disease, severe liver or kidney disease, and bipolar disorder may influence treatment selection, particularly with SSRIs.
Treatment Options
Treatment is layered: behavioral techniques first, with topical or pharmacological options added as needed. Most men respond well to a combination approach.
- Behavioral techniques -- The start-stop method (Semans technique) and the squeeze method (Masters and Johnson) train ejaculation control. Pelvic floor exercises also improve outcomes.
- Topical anesthetics -- Lidocaine-prilocaine 5% cream or lidocaine spray applied to the glans 20-30 minutes before sex reduces sensitivity. Studies show 6-8 fold increases in ejaculation latency.
- Off-label SSRIs -- Paroxetine 20 mg daily, sertraline 50-100 mg daily, or fluoxetine 20 mg daily are well-studied off-label treatments that delay ejaculation by altering serotonin signaling. Effects are seen within 1-2 weeks; full benefit at 4-6 weeks.
- On-demand dapoxetine -- Approved in Europe and some other countries but not currently marketed in Canada; physicians may discuss this if patients are traveling or considering compounded options.
- PDE5 inhibitors when ED coexists -- Sildenafil or tadalafil resolve PE in many men whose PE is driven by anxiety about losing an erection.
- Counseling or sex therapy -- Individual or couples therapy is highly effective when relationship or anxiety factors contribute.
The Virtual Consultation Process
The TelePlus Care consultation for PE is fully virtual, structured around a thorough sexual health history and a personalized treatment plan.
- Step 1 -- Online intake. Complete a confidential questionnaire covering your medical history, current medications, sexual history, and the timing and context of PE symptoms.
- Step 2 -- Video consultation with an Alberta-licensed physician. The physician explores whether PE is lifelong or acquired, screens for ED and anxiety, and reviews your medications.
- Step 3 -- Treatment plan. The physician recommends behavioral techniques, may prescribe a topical anesthetic, and discusses oral SSRI options if appropriate.
- Step 4 -- Prescription. Any prescription is issued for you to fill at any Canadian pharmacy.
- Step 5 -- Follow-up. A check-in at 4-6 weeks to evaluate response, manage side effects, and adjust the regimen as needed.
Cost of PE Treatment in Canada
PE treatment is generally affordable, with most options costing modest monthly amounts at Canadian pharmacies. The consultation fee is the largest single expense for many patients.
- Initial virtual consultation -- Approximately $89, often covered by AHCIP for valid Alberta Health cardholders.
- Lidocaine-prilocaine 5% cream (30 g tube) -- Approximately $20-40 at Canadian pharmacies; many tubes last several months.
- Lidocaine 10% spray -- Approximately $25-45 per bottle.
- Generic paroxetine 20 mg (30-tablet pack) -- Approximately $10-25 per month.
- Generic sertraline 50 mg (30-tablet pack) -- Approximately $10-30 per month.
- Insurance coverage -- Topical anesthetics are not generally covered. Generic SSRIs are often partially covered by Alberta Drug Benefit Plan or private insurance, though usually only for approved indications such as depression.
Side Effects and Safety
Each treatment option has a different side-effect profile. Your physician will explain what to expect and how to manage any side effects.
- Topical anesthetics -- Mild numbness, transient skin irritation, or transfer to a partner if not used with a condom or wiped off before intercourse.
- SSRIs -- Nausea, fatigue, sleep changes, decreased libido, and delayed ejaculation are expected. Risk of serotonin syndrome if combined with other serotonergic medications. Discontinuation should be gradual to avoid withdrawal symptoms.
- Drug interactions -- SSRIs interact with MAOIs, tramadol, lithium, and certain migraine medications; full medication review at consultation.
- Cardiac considerations -- Some SSRIs prolong the QT interval; baseline cardiac history is reviewed.
- Mental health -- Patients with bipolar disorder require careful evaluation before SSRI use, as SSRIs can trigger mania.
- Pregnancy and partners -- Topical anesthetics applied without a condom can transfer; SSRIs require careful consideration if a partner is pregnant or trying to conceive.
Why Choose TelePlus Care for PE Treatment?
PE is common but rarely discussed. TelePlus Care offers a discreet, judgment-free space to address it with evidence-based care.
- Real physician consultations -- Every treatment plan is built by an Alberta-licensed physician, not an algorithm.
- Layered treatment approach -- Behavioral, topical, and oral options used in combination based on what works for you.
- Discreet and confidential -- All visits are private; records protected under PIPEDA and Alberta's HIA.
- Fill at any Canadian pharmacy -- Your prescription is portable.
- Same-week appointments -- Most consultations available within 24-72 hours.
- Follow-up included -- Structured 4-6 week review to optimize your regimen.
Your Fast and Convenient Healthcare Solution
Connect with a licensed healthcare provider from the comfort of your home. No referral needed — book your virtual appointment today.
Book Your Appointment Now
Serving Communities Across Alberta
All Canadian provinces and territories. Headquartered in Alberta with primary service across Edmonton, Calgary, Red Deer, Lethbridge, and surrounding communities.
Teleplus care clinic is not an urgent care clinic. If you have an emergency please call 911 or go to the nearest urgent care facility.
